Composants NBI
Les constituants NASDAQ Biotechnology sont disponibles dans le tableau ci-dessous. Triez les composants de l'action NBI selon diverses mesures et données financières telles que la performance, les dividendes, le compte de résultat et le bilan.
Symbole | Capitalisation boursière | Prix | Variation % | Volume | Volume Rel | P/E | BPA dil TTM | Croissance dil du BPA YoY TTM | Rendement du Dividende % TTM | Secteur | Note des analystes |
|---|---|---|---|---|---|---|---|---|---|---|---|
 AZNAstraZeneca PLCDR | 195,52 B USD | 63,20 USD | −0,94% | 7,05 M | 0,71 | 30,37 | 2,08 USD | +10,04% | 2,30% | Technologie de la santé | Buy |
 AMGNAmgen Inc. | 154,74 B USD | 287,87 USD | +2,83% | 4,76 M | 1,36 | 36,86 | 7,81 USD | −44,46% | 3,08% | Technologie de la santé | Buy |
 SNYSanofiDR | 120,68 B USD | 47,78 USD | −0,46% | 1,74 M | 0,70 | 26,34 | 1,81 USD | −38,99% | 3,09% | Technologie de la santé | Buy |
 VRTXVertex Pharmaceuticals Incorporated | 116,2 B USD | 451,23 USD | +0,72% | 1,65 M | 1,11 | — | −1,99 USD | −114,96% | 0,00% | Technologie de la santé | Buy |
 GILDGilead Sciences, Inc. | 110,46 B USD | 88,63 USD | +1,00% | 4,78 M | 0,50 | 999,21 | 0,09 USD | −98,10% | 3,45% | Technologie de la santé | Buy |
 REGNRegeneron Pharmaceuticals, Inc. | 81,69 B USD | 743,35 USD | −0,17% | 654,57 K | 0,76 | 18,39 | 40,41 USD | +15,25% | 0,00% | Technologie de la santé | Buy |
 ARGXargenx SEDR | 35,23 B USD | 591,82 USD | +3,01% | 382,27 K | 1,20 | — | −3,50 USD | +79,68% | 0,00% | Technologie de la santé | Strong Buy |
 ALNYAlnylam Pharmaceuticals, Inc. | 32,09 B USD | 248,79 USD | +6,20% | 1,06 M | 1,03 | — | −2,62 USD | +36,82% | 0,00% | Technologie de la santé | Buy |
 BNTXBioNTech SEDR | 24,49 B USD | 102,14 USD | −4,00% | 1,13 M | 0,81 | — | −2,15 USD | −118,72% | 0,00% | Technologie de la santé | Strong Buy |
 BIIBBiogen Inc. | 22,73 B USD | 156,00 USD | +0,37% | 1,63 M | 0,95 | 14,09 | 11,07 USD | +10,06% | 0,00% | Technologie de la santé | Buy |
 BGNEBeiGene, Ltd.DR | 21,8 B USD | 194,26 USD | +3,46% | 344,28 K | 1,14 | — | −8,24 USD | +11,11% | 0,00% | Technologie de la santé | Strong Buy |
 ILMNIllumina, Inc. | 20,88 B USD | 131,68 USD | −2,46% | 3,07 M | 1,21 | — | −10,00 USD | −40,39% | 0,00% | Technologie de la santé | Buy |
 UTHRUnited Therapeutics Corporation | 16,27 B USD | 364,33 USD | +1,00% | 199,25 K | 0,50 | 16,00 | 22,77 USD | +25,44% | 0,00% | Technologie de la santé | Buy |
 VTRSViatris Inc. | 15,67 B USD | 13,13 USD | +0,61% | 8,77 M | 0,87 | — | −0,74 USD | −148,99% | 3,66% | Technologie de la santé | Neutre |
 RPRXRoyalty Pharma plc | 15,45 B USD | 26,22 USD | +0,81% | 2,01 M | 0,50 | 10,26 | 2,56 USD | +538,81% | 3,17% | Technologie de la santé | Strong Buy |
 MRNAModerna, Inc. | 14,22 B USD | 36,94 USD | −0,94% | 7,34 M | 0,54 | — | −5,82 USD | +37,62% | 0,00% | Technologie de la santé | Neutre |
 SMMTSummit Therapeutics Inc. | 13,73 B USD | 18,62 USD | −6,90% | 1,78 M | 0,94 | — | −0,28 USD | +82,45% | 0,00% | Technologie de la santé | Buy |
 INCYIncyte Corporation | 13,69 B USD | 71,05 USD | +0,69% | 2,31 M | 0,66 | 503,19 | 0,14 USD | −92,50% | 0,00% | Technologie de la santé | Buy |
 GMABGenmab A/SDR | 13,45 B USD | 20,45 USD | −0,24% | 1,2 M | 0,72 | 19,70 | 1,04 USD | +10,05% | 0,00% | Technologie de la santé | Buy |
 INSMInsmed Incorporated | 13 B USD | 72,67 USD | −1,42% | 1,71 M | 0,92 | — | −5,56 USD | −5,41% | 0,00% | Technologie de la santé | Strong Buy |
 NBIXNeurocrine Biosciences, Inc. | 12,48 B USD | 123,29 USD | +3,49% | 1,44 M | 1,47 | 33,03 | 3,73 USD | +99,71% | 0,00% | Technologie de la santé | Strong Buy |
 BMRNBioMarin Pharmaceutical Inc. | 11,92 B USD | 62,56 USD | +0,95% | 1,25 M | 0,83 | 37,67 | 1,66 USD | +117,47% | 0,00% | Technologie de la santé | Buy |
 PCVXVaxcyte, Inc. | 10,71 B USD | 85,96 USD | −1,29% | 1,72 M | 0,77 | — | −4,68 USD | −40,18% | 0,00% | Technologie de la santé | Strong Buy |
 SRPTSarepta Therapeutics, Inc. | 10,59 B USD | 110,86 USD | +3,98% | 1,2 M | 0,86 | 92,09 | 1,20 USD | — | 0,00% | Technologie de la santé | Strong Buy |
 MEDPMedpace Holdings, Inc. | 10,14 B USD | 326,09 USD | +3,53% | 381,97 K | 0,81 | 28,55 | 11,42 USD | +33,83% | 0,00% | Services Commerciaux | Buy |
 EXELExelixis, Inc. | 9,9 B USD | 34,65 USD | +0,70% | 1,79 M | 0,81 | 22,08 | 1,57 USD | +459,23% | 0,00% | Technologie de la santé | Buy |
 RVMDRevolution Medicines, Inc. | 9,6 B USD | 57,07 USD | +1,06% | 843,98 K | 0,54 | — | −3,59 USD | −10,04% | 0,00% | Technologie de la santé | Strong Buy |
 ITCIIntra-Cellular Therapies Inc. | 9,08 B USD | 85,64 USD | +2,75% | 407,81 K | 0,57 | — | −0,86 USD | +47,14% | 0,00% | Technologie de la santé | Strong Buy |
 ROIVRoivant Sciences Ltd. | 8,36 B USD | 11,49 USD | +1,59% | 3,07 M | 0,56 | 2,03 | 5,66 USD | — | 0,00% | Technologie de la santé | Strong Buy |
 ASNDAscendis Pharma A/SDR | 7,43 B USD | 124,38 USD | −0,05% | 304,17 K | 0,49 | — | −8,10 USD | +28,89% | 0,00% | Technologie de la santé | Strong Buy |
 LEGNLegend Biotech CorporationDR | 7,36 B USD | 40,14 USD | +4,53% | 2,24 M | 1,20 | — | −1,91 USD | +35,99% | 0,00% | Technologie de la santé | Strong Buy |
 JAZZJazz Pharmaceuticals plc | 7,21 B USD | 119,24 USD | +2,07% | 407,17 K | 0,45 | 17,17 | 6,94 USD | +1 051,97% | 0,00% | Technologie de la santé | Buy |
 MDGLMadrigal Pharmaceuticals, Inc. | 6,92 B USD | 317,09 USD | +0,93% | 326,8 K | 0,64 | — | −25,07 USD | −30,31% | 0,00% | Technologie de la santé | Buy |
 GRFSGrifols, S.A.DR | 6,85 B USD | 8,60 USD | +1,65% | 828,07 K | 0,60 | — | — | — | 0,00% | Technologie de la santé | Neutre |
 NUVLNuvalent, Inc. | 6,48 B USD | 91,17 USD | +0,12% | 264,77 K | 0,63 | — | −3,48 USD | −71,14% | 0,00% | Technologie de la santé | Strong Buy |
 BPMCBlueprint Medicines Corporation | 6,02 B USD | 94,81 USD | +0,22% | 566,22 K | 0,88 | — | −2,11 USD | +77,09% | 0,00% | Technologie de la santé | Buy |
 CYTKCytokinetics, Incorporated | 5,88 B USD | 49,86 USD | −2,41% | 1,57 M | 0,94 | — | −5,39 USD | +2,40% | 0,00% | Technologie de la santé | Buy |
 HALOHalozyme Therapeutics, Inc. | 5,82 B USD | 45,76 USD | +2,12% | 1,88 M | 0,69 | 15,14 | 3,02 USD | +61,29% | 0,00% | Technologie de la santé | Buy |
 IONSIonis Pharmaceuticals, Inc. | 5,59 B USD | 35,40 USD | +4,89% | 2,22 M | 1,66 | — | −2,44 USD | +14,63% | 0,00% | Technologie de la santé | Buy |
 RNAAvidity Biosciences, Inc. | 5,21 B USD | 43,65 USD | +0,92% | 675,47 K | 0,47 | — | −2,90 USD | +3,08% | 0,00% | Technologie de la santé | Strong Buy |
 CRNXCrinetics Pharmaceuticals, Inc. | 5,2 B USD | 56,07 USD | +1,63% | 493,58 K | 0,61 | — | −3,72 USD | −2,14% | 0,00% | Technologie de la santé | Strong Buy |
 KRYSKrystal Biotech, Inc. | 5,12 B USD | 178,10 USD | +0,14% | 180,57 K | 0,59 | 100,75 | 1,77 USD | — | 0,00% | Technologie de la santé | Strong Buy |
 ADMAADMA Biologics Inc | 5,05 B USD | 21,37 USD | +3,59% | 2,25 M | 0,54 | 77,34 | 0,28 USD | — | 0,00% | Technologie de la santé | Strong Buy |
 ACLXArcellx, Inc. | 4,72 B USD | 87,22 USD | −0,42% | 345,14 K | 0,51 | — | −0,75 USD | +73,14% | 0,00% | Technologie de la santé | Strong Buy |
 AXSMAxsome Therapeutics, Inc. | 4,58 B USD | 94,60 USD | −0,90% | 396,72 K | 0,52 | — | −6,54 USD | −44,44% | 0,00% | Technologie de la santé | Strong Buy |
 ALKSAlkermes plc | 4,52 B USD | 27,91 USD | +1,56% | 1,7 M | 1,00 | 14,22 | 1,96 USD | +59,05% | 0,00% | Technologie de la santé | Buy |
 BBIOBridgeBio Pharma, Inc. | 4,35 B USD | 23,04 USD | +2,22% | 1,4 M | 0,66 | — | −2,41 USD | +38,26% | 0,00% | Technologie de la santé | Strong Buy |
 RAREUltragenyx Pharmaceutical Inc. | 4,28 B USD | 46,40 USD | +2,81% | 696,22 K | 0,69 | — | −6,46 USD | +28,02% | 0,00% | Technologie de la santé | Strong Buy |
 CRSPCRISPR Therapeutics AG | 4,03 B USD | 47,26 USD | +0,62% | 1,95 M | 0,90 | — | −2,82 USD | +36,99% | 0,00% | Technologie de la santé | Buy |
 IMVTImmunovant, Inc. | 3,84 B USD | 26,17 USD | +3,77% | 1,01 M | 0,93 | — | −2,22 USD | −12,81% | 0,00% | Technologie de la santé | Strong Buy |
 GHGuardant Health, Inc. | 3,79 B USD | 30,68 USD | 0,00% | 1,59 M | 0,56 | — | −4,24 USD | −4,21% | 0,00% | Services de santé | Strong Buy |
 RYTMRhythm Pharmaceuticals, Inc. | 3,65 B USD | 59,36 USD | −1,02% | 388,32 K | 0,39 | — | −4,34 USD | −33,11% | 0,00% | Technologie de la santé | Strong Buy |
 DNLIDenali Therapeutics Inc. | 3,51 B USD | 24,42 USD | +0,33% | 767,97 K | 0,76 | — | −2,76 USD | −185,82% | 0,00% | Technologie de la santé | Strong Buy |
 APLSApellis Pharmaceuticals, Inc. | 3,42 B USD | 27,49 USD | −5,17% | 3,44 M | 0,75 | — | −2,04 USD | +61,20% | 0,00% | Technologie de la santé | Buy |
 IBRXImmunityBio, Inc. | 3,4 B USD | 4,88 USD | −8,88% | 5,06 M | 0,87 | — | −0,89 USD | +15,29% | 0,00% | Technologie de la santé | Buy |
 PTCTPTC Therapeutics, Inc. | 3,24 B USD | 41,96 USD | +6,61% | 723,04 K | 0,87 | — | −5,94 USD | +31,43% | 0,00% | Technologie de la santé | Neutre |
 VRNAVerona Pharma plcDR | 3,18 B USD | 38,85 USD | +2,00% | 1,41 M | 1,24 | — | −1,94 USD | −197,56% | 0,00% | Technologie de la santé | Strong Buy |
 HCMHUTCHMED (China) LimitedDR | 3,12 B USD | 17,96 USD | +7,22% | 94,53 K | 1,26 | — | −0,25 USD | +67,34% | 0,00% | Technologie de la santé | Strong Buy |
 AGIOAgios Pharmaceuticals, Inc. | 3,11 B USD | 54,62 USD | +0,39% | 367,69 K | 0,39 | 4,80 | 11,37 USD | — | 0,00% | Technologie de la santé | Buy |
 DYNDyne Therapeutics, Inc. | 3,05 B USD | 29,99 USD | +1,04% | 1,09 M | 0,83 | — | −3,56 USD | +0,90% | 0,00% | Technologie de la santé | Strong Buy |
 VCYTVeracyte, Inc. | 3,04 B USD | 39,20 USD | +0,13% | 632,02 K | 0,56 | — | −0,14 USD | +79,01% | 0,00% | Technologie de la santé | Buy |
 EWTXEdgewise Therapeutics, Inc. | 3,03 B USD | 31,95 USD | +1,40% | 346,02 K | 0,43 | — | −1,49 USD | −5,64% | 0,00% | Technologie de la santé | Strong Buy |
 XENEXenon Pharmaceuticals Inc. | 3 B USD | 39,34 USD | +1,26% | 409,69 K | 0,88 | — | −2,81 USD | −5,62% | 0,00% | Technologie de la santé | Strong Buy |
 MRUSMerus N.V. | 2,94 B USD | 42,93 USD | −1,29% | 678,23 K | 1,43 | — | −3,91 USD | −5,06% | 0,00% | Technologie de la santé | Strong Buy |
 VERAVera Therapeutics, Inc. | 2,9 B USD | 45,75 USD | −0,33% | 401,24 K | 0,45 | — | −2,60 USD | +9,55% | 0,00% | Technologie de la santé | Strong Buy |
 ZLABZai Lab LimitedDR | 2,89 B USD | 26,23 USD | +0,31% | 1,79 M | 1,21 | — | −2,78 USD | +10,91% | 0,00% | Technologie de la santé | Strong Buy |
 FOLDAmicus Therapeutics, Inc. | 2,87 B USD | 9,59 USD | +0,74% | 1,96 M | 0,63 | — | −0,35 USD | +41,95% | 0,00% | Technologie de la santé | Strong Buy |
 KYMRKymera Therapeutics, Inc. | 2,85 B USD | 44,05 USD | +2,82% | 385,46 K | 0,87 | — | −2,33 USD | +19,04% | 0,00% | Technologie de la santé | Strong Buy |
 VCELVericel Corporation | 2,83 B USD | 57,26 USD | +2,56% | 335,73 K | 0,64 | 916,16 | 0,06 USD | — | 0,00% | Technologie de la santé | Strong Buy |
 SWTXSpringWorks Therapeutics, Inc. | 2,79 B USD | 37,44 USD | −1,29% | 1,18 M | 0,59 | — | −3,73 USD | +23,69% | 0,00% | Technologie de la santé | Strong Buy |
 ACADACADIA Pharmaceuticals Inc. | 2,71 B USD | 16,27 USD | +0,37% | 1,09 M | 0,64 | 21,06 | 0,77 USD | — | 0,00% | Technologie de la santé | Buy |
 APGEApogee Therapeutics, Inc. | 2,64 B USD | 45,04 USD | −3,18% | 348,12 K | 0,69 | — | −2,73 USD | — | 0,00% | Technologie de la santé | Strong Buy |
 SRRKScholar Rock Holding Corporation | 2,61 B USD | 27,86 USD | 0,00% | 777,88 K | 0,83 | — | −2,47 USD | −9,56% | 0,00% | Technologie de la santé | Strong Buy |
 JANXJanux Therapeutics, Inc. | 2,57 B USD | 48,96 USD | −0,10% | 391,49 K | 0,58 | — | −1,18 USD | +20,33% | 0,00% | Technologie de la santé | Strong Buy |
 IOVAIovance Biotherapeutics, Inc. | 2,48 B USD | 8,14 USD | −0,61% | 6,01 M | 0,49 | — | −1,50 USD | +28,07% | 0,00% | Technologie de la santé | Strong Buy |
 TWSTTwist Bioscience Corporation | 2,44 B USD | 41,11 USD | −0,51% | 760,07 K | 0,64 | — | −3,60 USD | −0,07% | 0,00% | Technologie de la santé | Buy |
 PTGXProtagonist Therapeutics, Inc. | 2,42 B USD | 40,65 USD | +5,17% | 1,05 M | 1,12 | 15,25 | 2,67 USD | — | 0,00% | Technologie de la santé | Strong Buy |
 GERNGeron Corporation | 2,41 B USD | 3,99 USD | +5,28% | 9,51 M | 0,68 | — | −0,32 USD | +5,76% | 0,00% | Technologie de la santé | Strong Buy |
 ARWRArrowhead Pharmaceuticals, Inc. | 2,33 B USD | 18,71 USD | +0,59% | 792,15 K | 0,61 | — | −4,65 USD | −172,17% | 0,00% | Technologie de la santé | Buy |
 IDYAIDEAYA Biosciences, Inc. | 2,21 B USD | 25,54 USD | −1,24% | 545,59 K | 0,65 | — | −2,33 USD | −19,54% | 0,00% | Technologie de la santé | Strong Buy |
 CNTACentessa Pharmaceuticals plcDR | 2,2 B USD | 16,74 USD | −0,53% | 711,49 K | 0,94 | — | −1,53 USD | +7,72% | 0,00% | Technologie de la santé | Strong Buy |
 KROSKeros Therapeutics, Inc. | 2,19 B USD | 54,14 USD | +0,97% | 408,55 K | 0,82 | — | −5,21 USD | −5,26% | 0,00% | Technologie de la santé | Strong Buy |
 WVEWave Life Sciences Ltd. | 2,17 B USD | 14,26 USD | +0,35% | 679,44 K | 0,45 | — | −1,11 USD | −28,14% | 0,00% | Technologie de la santé | Strong Buy |
 AKROAkero Therapeutics, Inc. | 2,14 B USD | 30,64 USD | −1,27% | 539,08 K | 0,68 | — | −3,75 USD | −59,03% | 0,00% | Technologie de la santé | Strong Buy |
 AMPHAmphastar Pharmaceuticals, Inc. | 2,12 B USD | 44,09 USD | +1,08% | 607,14 K | 1,14 | 14,67 | 3,01 USD | +17,33% | 0,00% | Technologie de la santé | Buy |
 LGNDLigand Pharmaceuticals Incorporated | 2,11 B USD | 111,56 USD | −0,21% | 133,56 K | 0,76 | 44,39 | 2,51 USD | +200,39% | 0,00% | Technologie de la santé | Strong Buy |
 MIRMMirum Pharmaceuticals, Inc. | 2,1 B USD | 43,69 USD | +3,80% | 450,89 K | 0,88 | — | −2,07 USD | +52,00% | 0,00% | Technologie de la santé | Strong Buy |
 BEAMBeam Therapeutics Inc. | 2,03 B USD | 24,49 USD | −3,16% | 1,21 M | 0,86 | — | −1,76 USD | +57,86% | 0,00% | Technologie de la santé | Buy |
 SUPNSupernus Pharmaceuticals, Inc. | 1,99 B USD | 36,12 USD | +1,66% | 203,92 K | 0,46 | 33,82 | 1,07 USD | +175,07% | 0,00% | Technologie de la santé | Buy |
 MNKDMannKind Corporation | 1,9 B USD | 6,88 USD | +0,29% | 1,93 M | 0,56 | 97,87 | 0,07 USD | — | 0,00% | Technologie de la santé | Strong Buy |
 GPCRStructure Therapeutics Inc.DR | 1,87 B USD | 32,71 USD | −0,21% | 783,24 K | 0,90 | — | −2,21 USD | +3,70% | 0,00% | Technologie de la santé | Strong Buy |
 HRMYHarmony Biosciences Holdings, Inc. | 1,87 B USD | 32,79 USD | +0,95% | 311,03 K | 0,51 | 15,52 | 2,11 USD | −14,38% | 0,00% | Technologie de la santé | Buy |
 IRONDisc Medicine, Inc. | 1,86 B USD | 62,55 USD | +5,04% | 263,33 K | 0,75 | — | −3,97 USD | −6,02% | 0,00% | Technologie de la santé | Strong Buy |
 NVCRNovoCure Limited | 1,82 B USD | 16,86 USD | +2,31% | 673,96 K | 0,75 | — | −1,39 USD | +25,11% | 0,00% | Technologie de la santé | Buy |
 TARSTarsus Pharmaceuticals, Inc. | 1,78 B USD | 46,58 USD | −0,66% | 356,38 K | 0,36 | — | −3,81 USD | +0,54% | 0,00% | Technologie de la santé | Strong Buy |
 GLPGGalapagos NVDR | 1,73 B USD | 25,64 USD | −3,93% | 516,28 K | 1,41 | — | — | — | 0,00% | Technologie de la santé | Neutre |
 RXRXRecursion Pharmaceuticals, Inc. | 1,73 B USD | 6,04 USD | −3,67% | 17 M | 1,98 | — | −1,53 USD | −4,26% | 0,00% | Technologie de la santé | Neutre |
 FTREFortrea Holdings Inc. | 1,72 B USD | 19,15 USD | +2,52% | 1,22 M | 0,63 | — | −3,14 USD | — | 0,00% | Services Commerciaux | Neutre |
 XNCRXencor, Inc. | 1,66 B USD | 23,72 USD | +0,38% | 546,63 K | 0,68 | — | −3,20 USD | −61,20% | 0,00% | Technologie de la santé | Buy |
 IMCRImmunocore Holdings plcDR | 1,62 B USD | 32,42 USD | −0,43% | 128,28 K | 0,51 | — | −0,96 USD | +29,29% | 0,00% | Technologie de la santé | Buy |